Cernelle enters China

2021-09-08T12:13:00+02:00

Cernelle enters China. AB Cernelle, in partnership with MeiRui, a leading Chinese pharmaceutical company specialising in urology, has received approval for Shenitong®, which is an herbal medicinal product for the treatment of benign prostate diseases. Both companies are now preparing for the market launch of Shenitong®, with the product expected to be available on the [Read more]